Zacks Investment ResearchFri, 20 Mar 2026 17:01:25 GMTProtagonist Therapeutics Stock Rallies Nearly 7% in a Week: Here's WhyPTGX-0.48%
Zacks Investment ResearchFri, 20 Mar 2026 14:06:11 GMTProtagonist Therapeutics (PTGX) Soars 4.7%: Is Further Upside Left in the Stock?PTGX-0.48%
Seeking AlphaWed, 18 Mar 2026 19:52:21 GMTProtagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of ICOTYDE for Moderate to Severe Plaque Psoriasis Treatment TranscriptPTGX-0.48%
The Motley FoolWed, 25 Feb 2026 20:28:39 GMTProtagonist Stock Up 120%, but One Fund Just Revealed a $170 Million ExitPTGX-0.48%
The Motley FoolMon, 16 Feb 2026 08:38:10 GMTProtagonist Therapeutics Director Sells 20,000 Shares Amid Strong Stock PerformancePTGX-0.48%
The Motley FoolSun, 01 Feb 2026 05:25:17 GMTProtagonist Therapeutics Chief Medical Officer Sells PTGX 9,514 Shares for $784K to Cover TaxesPTGX-0.48%
